LL-37: What It Is and How It's Used in the Philippines
LL-37 reference for Filipino peptide users. Antimicrobial peptide, anti-biofilm. Research peptide, limited PH community adoption.
LL-37: What It Is and How It's Used in the Philippines
Quick read: LL-37 is an antimicrobial peptide derived from cathelicidin. It has broad-spectrum antimicrobial and anti-biofilm properties. Dosing varies (research peptide). In PH, it's niche with limited community adoption.
What it is
LL-37 is a 37-amino-acid peptide with antimicrobial activity against bacteria, viruses, and fungi. It also disrupts biofilms.
Research shows LL-37 supports immune function and wound healing.
In the PH peptide community, LL-37 is rare, used experimentally for immune support or chronic infections.
What it's used for
Primary use: Antimicrobial support (experimental).
Realistic expectations: Limited community data.
Typical protocols
Dosing protocols are not well-established. Research peptide.
What users typically report
Very limited community data.
Common side effects
Side effects are poorly documented.
Side effect management
Unknown.
Who this compound is for
Experimental use only. Niche.
Who this compound is NOT for
Pregnancy/breastfeeding.
People unwilling to use compounds with minimal data.
PH-specific considerations
Niche use, limited PH community adoption.
Common stacks
Typically run standalone.
Things to watch
Unknown.
Coming off / cycling
Unknown.
Related compounds
- BPC-157 — General healing
- Thymosin Alpha-1 — Immune support
Sources
- Vandamme 2012 — LL-37 antimicrobial mechanisms
- Wuerth 2017 — LL-37 and biofilm disruption
Last updated: 2026-05-20. This page is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.